Lundbeck and OpenAI Collaborate to Boost Innovation
Lundbeck, a biopharmaceutical company, announced a strategic collaboration with OpenAI to transform innovation and operations across its value chain.
Lundbeck focuses exclusively on brain health, with over 70 years of experience in neuroscience, aiming to improve lives of people with neurological and psychiatric diseases.
Brain disorders affect a large part of the world’s population, and the effects are felt throughout society.
With a rapidly improving understanding of brain biology, Lundbeck seeks to advance brain health by exploring new treatment opportunities.
As a focused innovator, Lundbeck's research and development programs tackle complex neurological challenges.
Author's summary: Lundbeck partners with OpenAI to innovate brain health solutions.